Angiotensin 2 Receptor Blocker class drugs

46 results

  • amlodipine and olmesartan medoxomil

    (AMLODIPINE and OLMESARTAN medoxomil)
    Macleods Pharmaceuticals Limited
    Amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce cardiovascular event risks, including strokes and heart attacks. They may also serve as initial therapy for patients needing multiple agents.
    Medication Details
    Drug Interactions

  • amlodipine besylate and olmesartan medoxomil

    (Amlodipine besylate and Olmesartan medoxomil)
    Ajanta Pharma USA Inc.
    Amlodipine and olmesartan medoxomil tablets are indicated for hypertension treatment, either alone or with other antihypertensives, to reduce blood pressure and the risk of cardiovascular events, such as strokes and myocardial infarctions. They may be used as initial therapy for patients likely needing multiple medications to reach blood pressure goals.
    Medication Details
    Drug Interactions

  • atacand

    (Candesartan Cilexetil)
    ANI Pharmaceuticals, Inc.
    ATACAND is indicated for treating hypertension in adults and children aged 1-17, reducing cardiovascular event risks. It is also indicated for heart failure in adults with left ventricular systolic dysfunction (ejection fraction ≤ 40%) to decrease cardiovascular deaths and hospitalizations.
    Medication Details
    Drug Interactions

  • atacand hct

    (Candesartan Cilexetil and Hydrochlorothiazide)
    ANI Pharmaceuticals, Inc.
    ATACAND HCT is indicated for treating hypertension to lower blood pressure, thereby reducing the risk of cardiovascular events like strokes and myocardial infarctions. It is not meant for initial therapy and should be part of a broader cardiovascular risk management strategy.
    Medication Details
    Drug Interactions

  • benicar

    (olmesartan medoxomil)
    Cosette Pharmaceuticals, Inc.
    Benicar is indicated for treating hypertension in adults and children aged six and older to lower blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.
    Medication Details
    Drug Interactions

  • benicar hct

    (olmesartan medoxomil-hydrochlorothiazide)
    Cosette Pharmaceuticals, Inc.
    BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension to lower blood pressure. It is not intended for initial therapy and may be used alone or with other antihypertensive medications to reduce cardiovascular risk, including strokes and myocardial infarctions.
    Medication Details
    Drug Interactions

  • candesartan

    (Candesartan)
    NorthStar RxLLC
    Candesartan cilexetil tablets are indicated for treating hypertension in adults and children (1 to <17 years) to lower blood pressure, reducing cardiovascular event risks. They are also used for heart failure management (NYHA class II-IV) in adults with left ventricular systolic dysfunction, decreasing cardiovascular deaths and hospitalizations.
    Medication Details
    Drug Interactions

  • candesartan cilexetil

    (Candesartan cilexetil)
    ANI Pharmaceuticals, Inc.
    Candesartan cilexetil is indicated for treating hypertension in adults and children (1 to <17 years), and for heart failure in adults with left ventricular systolic dysfunction (ejection fraction ≤ 40%). It reduces cardiovascular risks, including death and hospitalizations related to heart failure.
    Medication Details
    Drug Interactions

  • candesartan cilexetil and hydrochlorothiazide

    (candesartan cilexetil and hydrochlorothiazide)
    Mylan Pharmaceuticals Inc.
    Candesartan cilexetil and hydrochlorothiazide are indicated for hypertension management, helping to lower blood pressure and reduce the risk of cardiovascular events such as strokes and heart attacks. It is intended as part of a comprehensive cardiovascular risk management approach, and not for initial therapy.
    Medication Details
    Drug Interactions